BUZZ-Jefferies updates ratings on life sciences firms for 2026
I'm PortAI, I can summarize articles.
Jefferies updates ratings for life sciences firms for 2026. Maintains "buy" for Waters, Neogenomics, and Danaher Corp, citing growth prospects. Downgrades Avantor to "underperform" due to structural challenges. Reiterates "hold" for Illumina amid uncertainties. Adjusted price targets: Waters $470, Neogenomics $15, Avantor $9, Danaher Corp $255, Illumina $125.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments